Making The Case For Vaccines In Europe: A Conversation With Sanofi’s Andrea Rappagliosi
Sanofi Pasteur MSD’s Andrea Rappagliosi also is president of Vaccines Europe, an industry group that just launched an initiative to promote the preventive health value of vaccines.
You may also be interested in...
GSK believes detrimental government policies such as reference pricing and tendering in the vaccines sector are threatening this part of the pharmaceutical industry, and patient health.
MHRA’s Beneficial EU Relationship And Profitable Synergies With NICE: An Interview With Michael Rawlins
In December, Michael Rawlins was appointed head of the U.K.’s Medicines and Healthcare products Regulatory Agency. He recognizes the MHRA’s mutually beneficial relationship with European counterparts and is looking to safeguard synergies with other national regulatory bodies and NICE.
The EMA has recommended suspension of some 700 drug formations linked with Indian clinical trials company GVK Biosciences, but assures national agencies that this won’t result in shortages or safety issues.